SCHEMBL19923646

SCHEMBL19923646

CC[Si](CC)(CC)N1C(=O)N(C(C)C)C(C)(c2ccccc2)C1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
BACE1 P56817 3/20 0.35
BACE2 Q9Y5Z0 2/20 0.35
TSHR P16473 2/20 0.34
TP53 P04637 1/20 0.34
LMNA P02545 2/20 0.34
GRM4 Q14833 1/20 0.34
CYP2C19 P33261 1/20 0.33
ELANE P08246 2/20 0.33
GRM5 P41594 1/20 0.32
CTSD P07339 1/20 0.32
CTSE P14091 1/20 0.32
HTR1A P08908 1/20 0.32
HTR6 P50406 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
GAA P10253 1/20 0.32
REN P00797 1/20 0.31
APP P05067 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19923405 0.90 ALDH1A1 (0.34) ALDH1A1SMN1; SMN2BACE1BACE2TSHR
SCHEMBL19923400 0.84 SMN1; SMN2 (0.36) ALDH1A1SMN1; SMN2BACE1BACE2TSHR
SCHEMBL19923705 0.84 ALDH1A1 (0.37) ALDH1A1BACE1BACE2TSHRTP53
SCHEMBL19923594 0.84 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2BACE1BACE2TSHR
SCHEMBL19923549 0.82 TSHR (0.38) ALDH1A1BACE1BACE2TSHRTP53
SCHEMBL19923757 0.82 MITF (0.39) SMN1; SMN2BACE1BACE2TSHRLMNA
SCHEMBL19923502 0.81 BACE1 (0.38) ALDH1A1BACE1BACE2TSHRTP53
SCHEMBL19923432 0.81 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2BACE1BACE2TSHR
SCHEMBL19923574 0.80 ELANE (0.37) ALDH1A1BACE1BACE2TSHRTP53
SCHEMBL19923440 0.80 GRM4 (0.33) GRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US claimed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US claimed
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US disclosed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS PARG, HNMT, PARN ALDH1A1 2648/4885SMN1; SMN2 1697/4885BACE1 4315/4885
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds HNMT, PARG, PAM ALDH1A1 2554/4885SMN1; SMN2 1924/4885BACE1 4432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.